In this current age of genome biology, the primary objective of the Genomics Core is to accelerate the study of HIV and opportunistic infections associated with AIDS by providing researchers with access to genomic technologies. Examining host genetics following pathogen infection can identify new targets and pathways for drug development, reveal the genetic mechanisms of disease pathogenesis, determine predictive gene expression profiles that can guide treatment options, and identify single nucleotide polymorphisms (SNPs) associated with disease that can be used to judge the effectiveness of different antiviral drug therapies. To facilitate such research, the specific aims of the Genomics Core are as follows: (1) to provide researchers with a cost-effective mechanism to analyze mammalian gene expression at the whole genome level using microarray technology, (2) to enable the more precise quantification of both coding and non-coding gene expression using real-time quantitative RT-PCR (qRT-PCR), (3) to screen large numbers of samples for specific SNPs, and (4) to offer expertise and training in bioinformatics applications required to process and interpret the data generated by genomic technologies. The Genomics Core is currently outfitted with a suite of laboratory equipment to meet these aims (2 x ABI Prism 7700 Sequence Detection Systems, a Bio-Rad iCycler, an Affymetrix Fluidics Station 400 and a Sun Microsystems Sunfire 250 Enterprise server). Staff at the core are highly trained and skilled in areas of nucleic acid isolation, purification and quantification, and primer design, gene expression assays and bioinformatic analysis. In summary, the contribution of the Genomics Core to HIV- and AIDS-related research is best reflected by the numerous projects supported by the core, among which include the first assessment of HIV-stimulated gene expression in CD4 T cells, identification of pathways resulting in HIV induced apoptosis, the effects of methamphetamine use on HIV encephalitis, and identification of the amino acid polymorphisms that contribute to ritonavir hypersusceptibility. This proposal will allow the Genomics Core to continue bridging the gap between HIV-related research and genomic technologies in an economical manner. This will allow HIV research to benefit from the very latest developments in genome biology, which will ultimately translate into a better understanding of disease pathogenesis and the evolution of better therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-16
Application #
7872812
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
16
Fiscal Year
2009
Total Cost
$309,448
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Groessl, Erik J; Ganiats, Theodore G; Hillery, Naomi et al. (2018) Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis 18:102
Dillon, Stephanie M; Guo, Kejun; Austin, Gregory L et al. (2018) A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS 32:1599-1611
Goldenberg, Shira M; Rocha Jiménez, Teresita; Brouwer, Kimberly C et al. (2018) Influence of indoor work environments on health, safety, and human rights among migrant sex workers at the Guatemala-Mexico Border: a call for occupational health and safety interventions. BMC Int Health Hum Rights 18:9
Mehta, Sanjay R; Chaillon, Antoine; Gaines, Tommi L et al. (2018) Impact of Public Safety Policies on Human Immunodeficiency Virus Transmission Dynamics in Tijuana, Mexico. Clin Infect Dis 66:758-764
Dinesha, T R; Boobalan, J; Sivamalar, S et al. (2018) Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 25:718-723
Fraser, Hannah; Zibbell, Jon; Hoerger, Thomas et al. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:173-182
Dinesha, Thongadi Ramesh; Boobalan, Jayaseelan; Sivamalar, Sathasivam et al. (2018) HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India. AIDS Res Hum Retroviruses 34:327-328
Steinhardt, James J; Guenaga, Javier; Turner, Hannah L et al. (2018) Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity. Nat Commun 9:877
Thaney, Victoria E; Sanchez, Ana B; Fields, Jerel A et al. (2018) Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 24:156-167
Stecher, Melanie; Hoenigl, Martin; Eis-Hübinger, Anna Maria et al. (2018) Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany. Clin Infect Dis :

Showing the most recent 10 out of 921 publications